Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
IONS Analyst Ratings
Moderate Buy
12 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IONS Stock 12 Month Forecast
Average Price Target
$55.47
▲(95.32% Upside)
| Highest Price Target$78.00 | Average Price Target$55.47 | Lowest Price Target$38.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
04/15/25
William Blair
Reiterated
04/15/25
Needham
Reiterated
04/15/25
H.C. Wainwright
Reiterated
04/15/25
Bank of America Securities
Reiterated
04/14/25
Morgan Stanley
Reiterated
04/11/25
Citi
Reiterated
04/03/25
Wells Fargo
Reiterated
04/03/25
Redburn Atlantic
Initiated
03/31/25
J.P. Morgan
$47→$45
Hold
58.45%
Upside
Reiterated
03/24/25
Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorganIonis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
Leerink Partners
$52→$55
Buy
93.66%
Upside
Reiterated
03/13/25
Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating
Oppenheimer
$78
Buy
174.65%
Upside
Reiterated
03/12/25
Oppenheimer reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)Oppenheimer analyst Jay Olson reiterated an Outperform rating and $78.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).
Stifel Nicolaus
$38
Hold
33.80%
Upside
Reiterated
02/23/25
Stifel Nicolaus Remains a Hold on Ionis Pharmaceuticals (IONS)
Bernstein
$51→$43
Hold
51.41%
Upside
Reiterated
02/21/25
Ionis Pharmaceuticals (IONS) PT Lowered to $43 at Bernstein SocGen GroupBernstein SocGen Group analyst William Pickering lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $43.00 (from $51.00) while maintaining a Market Perform rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
04/15/25
William Blair
Reiterated
04/15/25
Needham
Reiterated
04/15/25
H.C. Wainwright
Reiterated
04/15/25
Bank of America Securities
Reiterated
04/14/25
Morgan Stanley
Reiterated
04/11/25
Citi
Reiterated
04/03/25
Wells Fargo
Reiterated
04/03/25
Redburn Atlantic
Initiated
03/31/25
J.P. Morgan
$47→$45
Hold
58.45%
Upside
Reiterated
03/24/25
Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorganIonis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
Leerink Partners
$52→$55
Buy
93.66%
Upside
Reiterated
03/13/25
Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating
Oppenheimer
$78
Buy
174.65%
Upside
Reiterated
03/12/25
Oppenheimer reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)Oppenheimer analyst Jay Olson reiterated an Outperform rating and $78.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).
Stifel Nicolaus
$38
Hold
33.80%
Upside
Reiterated
02/23/25
Stifel Nicolaus Remains a Hold on Ionis Pharmaceuticals (IONS)
Bernstein
$51→$43
Hold
51.41%
Upside
Reiterated
02/21/25
Ionis Pharmaceuticals (IONS) PT Lowered to $43 at Bernstein SocGen GroupBernstein SocGen Group analyst William Pickering lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $43.00 (from $51.00) while maintaining a Market Perform rating.
Best Analysts Covering Ionis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy IONS and Sell After:
1 Month
xxx
Success Rate
11/17 ratings generated profit
Average Return
+1.91%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +1.91% per trade.
3 Months
xxx
Success Rate
16/31 ratings generated profit
Average Return
+0.72%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.61% of your transactions generating a profit, with an average return of +0.72% per trade.
1 Year
Success Rate
11/17 ratings generated profit
Average Return
+12.44%
reiterated a buy rating 2 months ago
Copying Gary Nachman's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +12.44% per trade.
2 Years
xxx
Success Rate
11/17 ratings generated profit
Average Return
+15.41%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +15.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IONS Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
18
19
21
14
19
Buy
1
2
1
2
2
Hold
6
8
9
12
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
29
31
28
31
Each month's total comprises the sum of three months' worth of ratings.
IONS Financial Forecast
IONS Stock Forecast FAQ
What is IONS’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is 55.47.
What is IONS’s upside potential, based on the analysts’ average price target?
Ionis Pharmaceuticals has 95.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IONS a Buy, Sell or Hold?
Ionis Pharmaceuticals has a consensus rating of Moderate Buy which is based on 12 buy ratings, 8 hold ratings and 0 sell ratings.
What is Ionis Pharmaceuticals’s price target?
The average price target for Ionis Pharmaceuticals is 55.47. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $78.00 ,the lowest forecast is $38.00. The average price target represents 95.32% Increase from the current price of $28.4.
The highest analyst price target is $78.00 ,the lowest forecast is $38.00. The average price target represents 95.32% Increase from the current price of $28.4.
What do analysts say about Ionis Pharmaceuticals?
Ionis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of IONS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.